total lab quant 13 1v software Search Results


99
Dojindo Labs cck 8
Cck 8, supplied by Dojindo Labs, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/total+lab+quant+13+1v+software/10__1007_slash_s40843___018___9383___3-33-3-4?v=Dojindo+Labs
Average 99 stars, based on 1 article reviews
cck 8 - by Bioz Stars, 2026-07
99/100 stars
  Buy from Supplier

97
TotalLab Ltd total lab quant 13 1v software
Total Lab Quant 13 1v Software, supplied by TotalLab Ltd, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/total+lab+quant+13+1v+software/10__1016_slash_j__idairyj__2023__105590-65-9-13?v=TotalLab+Ltd
Average 97 stars, based on 1 article reviews
total lab quant 13 1v software - by Bioz Stars, 2026-07
97/100 stars
  Buy from Supplier

90
Meso Scale Diagnostics LLC v-plex human pro-inflammatory panel 1
V Plex Human Pro Inflammatory Panel 1, supplied by Meso Scale Diagnostics LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/total+lab+quant+13+1v+software/pmc07029330-133-18-11?v=Meso+Scale+Diagnostics+LLC
Average 90 stars, based on 1 article reviews
v-plex human pro-inflammatory panel 1 - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
RATHBURN CHEMICALS LIMITED n-hexane/propan-2-ol (hplc grade)
N Hexane/Propan 2 Ol (Hplc Grade), supplied by RATHBURN CHEMICALS LIMITED, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/total+lab+quant+13+1v+software/10__1016_slash_j__orggeochem__2018__03__012-55-9-14?v=RATHBURN+CHEMICALS+LIMITED
Average 90 stars, based on 1 article reviews
n-hexane/propan-2-ol (hplc grade) - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

98
Bio-Rad pbst
Pbst, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/total+lab+quant+13+1v+software/pm10417723-169-7-73?v=Bio-Rad
Average 98 stars, based on 1 article reviews
pbst - by Bioz Stars, 2026-07
98/100 stars
  Buy from Supplier

90
TIBCO v. 13.1
V. 13.1, supplied by TIBCO, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/total+lab+quant+13+1v+software/pm38257089-42-10-12?v=TIBCO
Average 90 stars, based on 1 article reviews
v. 13.1 - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

93
Proteintech atp6v1g1
Figure 3. NEO214 has an adverse effect on lysosomal function and blocked autophagic flux in glioma cells dependent on MTOR signaling. (A-B) Expression analysis of the autophagy-lysosome relevant genes in 100 μmol/L NEO214-treated U251 and T98G cells. (C) WB analysis of <t>ATP6V1G1,</t> ATP6V1D, ATP6V1H and ATP6V1C1 in U251 and T98G cells were treated with NEO214(100 μmol/L) in full-medium 24 h. (D) NEO214 does not affect the autophagosome formation process in glioma cells. Western blot analysis of the protein expression of BECN1, ATG3, ATG5, ATG9A, LC3, and SQSTM1 in U251 and T98G cells treated by 100 μmol/L NEO214 for 24 h. (E) Western blot analysis of MTOR signaling proteins expressions in U251 and T98G cells treated by 100 μmol/L NEO214 24 h. (n = 3; *, P < 0.05; **, P < 0.01; ***, P < 0.001).
Atp6v1g1, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/total+lab+quant+13+1v+software/pm37545052-330-149-150?v=Proteintech
Average 93 stars, based on 1 article reviews
atp6v1g1 - by Bioz Stars, 2026-07
93/100 stars
  Buy from Supplier

90
SAS institute sas v. 13.1
Figure 3. NEO214 has an adverse effect on lysosomal function and blocked autophagic flux in glioma cells dependent on MTOR signaling. (A-B) Expression analysis of the autophagy-lysosome relevant genes in 100 μmol/L NEO214-treated U251 and T98G cells. (C) WB analysis of <t>ATP6V1G1,</t> ATP6V1D, ATP6V1H and ATP6V1C1 in U251 and T98G cells were treated with NEO214(100 μmol/L) in full-medium 24 h. (D) NEO214 does not affect the autophagosome formation process in glioma cells. Western blot analysis of the protein expression of BECN1, ATG3, ATG5, ATG9A, LC3, and SQSTM1 in U251 and T98G cells treated by 100 μmol/L NEO214 for 24 h. (E) Western blot analysis of MTOR signaling proteins expressions in U251 and T98G cells treated by 100 μmol/L NEO214 24 h. (n = 3; *, P < 0.05; **, P < 0.01; ***, P < 0.001).
Sas V. 13.1, supplied by SAS institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/total+lab+quant+13+1v+software/pm37146471-66-31-33?v=SAS+institute
Average 90 stars, based on 1 article reviews
sas v. 13.1 - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

86
Merck & Co preparative tlc
Figure 3. NEO214 has an adverse effect on lysosomal function and blocked autophagic flux in glioma cells dependent on MTOR signaling. (A-B) Expression analysis of the autophagy-lysosome relevant genes in 100 μmol/L NEO214-treated U251 and T98G cells. (C) WB analysis of <t>ATP6V1G1,</t> ATP6V1D, ATP6V1H and ATP6V1C1 in U251 and T98G cells were treated with NEO214(100 μmol/L) in full-medium 24 h. (D) NEO214 does not affect the autophagosome formation process in glioma cells. Western blot analysis of the protein expression of BECN1, ATG3, ATG5, ATG9A, LC3, and SQSTM1 in U251 and T98G cells treated by 100 μmol/L NEO214 for 24 h. (E) Western blot analysis of MTOR signaling proteins expressions in U251 and T98G cells treated by 100 μmol/L NEO214 24 h. (n = 3; *, P < 0.05; **, P < 0.01; ***, P < 0.001).
Preparative Tlc, supplied by Merck & Co, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/total+lab+quant+13+1v+software/pm11457354__ja015715w_s1-63-16-18?v=Merck+%26+Co
Average 86 stars, based on 1 article reviews
preparative tlc - by Bioz Stars, 2026-07
86/100 stars
  Buy from Supplier

98
GE Healthcare hbs 13 buffer
Figure 3. NEO214 has an adverse effect on lysosomal function and blocked autophagic flux in glioma cells dependent on MTOR signaling. (A-B) Expression analysis of the autophagy-lysosome relevant genes in 100 μmol/L NEO214-treated U251 and T98G cells. (C) WB analysis of <t>ATP6V1G1,</t> ATP6V1D, ATP6V1H and ATP6V1C1 in U251 and T98G cells were treated with NEO214(100 μmol/L) in full-medium 24 h. (D) NEO214 does not affect the autophagosome formation process in glioma cells. Western blot analysis of the protein expression of BECN1, ATG3, ATG5, ATG9A, LC3, and SQSTM1 in U251 and T98G cells treated by 100 μmol/L NEO214 for 24 h. (E) Western blot analysis of MTOR signaling proteins expressions in U251 and T98G cells treated by 100 μmol/L NEO214 24 h. (n = 3; *, P < 0.05; **, P < 0.01; ***, P < 0.001).
Hbs 13 Buffer, supplied by GE Healthcare, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/total+lab+quant+13+1v+software/10__1016_slash_j__bmc__2019__05__040-241-7-23?v=GE+Healthcare
Average 98 stars, based on 1 article reviews
hbs 13 buffer - by Bioz Stars, 2026-07
98/100 stars
  Buy from Supplier

96
GE Healthcare rehydration buffer
Figure 3. NEO214 has an adverse effect on lysosomal function and blocked autophagic flux in glioma cells dependent on MTOR signaling. (A-B) Expression analysis of the autophagy-lysosome relevant genes in 100 μmol/L NEO214-treated U251 and T98G cells. (C) WB analysis of <t>ATP6V1G1,</t> ATP6V1D, ATP6V1H and ATP6V1C1 in U251 and T98G cells were treated with NEO214(100 μmol/L) in full-medium 24 h. (D) NEO214 does not affect the autophagosome formation process in glioma cells. Western blot analysis of the protein expression of BECN1, ATG3, ATG5, ATG9A, LC3, and SQSTM1 in U251 and T98G cells treated by 100 μmol/L NEO214 for 24 h. (E) Western blot analysis of MTOR signaling proteins expressions in U251 and T98G cells treated by 100 μmol/L NEO214 24 h. (n = 3; *, P < 0.05; **, P < 0.01; ***, P < 0.001).
Rehydration Buffer, supplied by GE Healthcare, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/total+lab+quant+13+1v+software/pmc03107904-176-19-11?v=GE+Healthcare
Average 96 stars, based on 1 article reviews
rehydration buffer - by Bioz Stars, 2026-07
96/100 stars
  Buy from Supplier

96
Bio-Rad wash buffer
Figure 3. NEO214 has an adverse effect on lysosomal function and blocked autophagic flux in glioma cells dependent on MTOR signaling. (A-B) Expression analysis of the autophagy-lysosome relevant genes in 100 μmol/L NEO214-treated U251 and T98G cells. (C) WB analysis of <t>ATP6V1G1,</t> ATP6V1D, ATP6V1H and ATP6V1C1 in U251 and T98G cells were treated with NEO214(100 μmol/L) in full-medium 24 h. (D) NEO214 does not affect the autophagosome formation process in glioma cells. Western blot analysis of the protein expression of BECN1, ATG3, ATG5, ATG9A, LC3, and SQSTM1 in U251 and T98G cells treated by 100 μmol/L NEO214 for 24 h. (E) Western blot analysis of MTOR signaling proteins expressions in U251 and T98G cells treated by 100 μmol/L NEO214 24 h. (n = 3; *, P < 0.05; **, P < 0.01; ***, P < 0.001).
Wash Buffer, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/total+lab+quant+13+1v+software/pm41187812-361-9-36?v=Bio-Rad
Average 96 stars, based on 1 article reviews
wash buffer - by Bioz Stars, 2026-07
96/100 stars
  Buy from Supplier

Image Search Results


Figure 3. NEO214 has an adverse effect on lysosomal function and blocked autophagic flux in glioma cells dependent on MTOR signaling. (A-B) Expression analysis of the autophagy-lysosome relevant genes in 100 μmol/L NEO214-treated U251 and T98G cells. (C) WB analysis of ATP6V1G1, ATP6V1D, ATP6V1H and ATP6V1C1 in U251 and T98G cells were treated with NEO214(100 μmol/L) in full-medium 24 h. (D) NEO214 does not affect the autophagosome formation process in glioma cells. Western blot analysis of the protein expression of BECN1, ATG3, ATG5, ATG9A, LC3, and SQSTM1 in U251 and T98G cells treated by 100 μmol/L NEO214 for 24 h. (E) Western blot analysis of MTOR signaling proteins expressions in U251 and T98G cells treated by 100 μmol/L NEO214 24 h. (n = 3; *, P < 0.05; **, P < 0.01; ***, P < 0.001).

Journal: Autophagy

Article Title: Inhibition of autophagy and induction of glioblastoma cell death by NEO214, a perillyl alcohol-rolipram conjugate.

doi: 10.1080/15548627.2023.2242696

Figure Lengend Snippet: Figure 3. NEO214 has an adverse effect on lysosomal function and blocked autophagic flux in glioma cells dependent on MTOR signaling. (A-B) Expression analysis of the autophagy-lysosome relevant genes in 100 μmol/L NEO214-treated U251 and T98G cells. (C) WB analysis of ATP6V1G1, ATP6V1D, ATP6V1H and ATP6V1C1 in U251 and T98G cells were treated with NEO214(100 μmol/L) in full-medium 24 h. (D) NEO214 does not affect the autophagosome formation process in glioma cells. Western blot analysis of the protein expression of BECN1, ATG3, ATG5, ATG9A, LC3, and SQSTM1 in U251 and T98G cells treated by 100 μmol/L NEO214 for 24 h. (E) Western blot analysis of MTOR signaling proteins expressions in U251 and T98G cells treated by 100 μmol/L NEO214 24 h. (n = 3; *, P < 0.05; **, P < 0.01; ***, P < 0.001).

Article Snippet: Immunoblotting was performed with PARP (Cell Signaling Technology, CS9542), LC3B (Cell Signaling Technology, CS-2775), SQSTM1/ p62 (Cell Signaling Technology, CS-5114), BECN1/beclin 1 (Cell Signaling Technology, CS-3738), RPTOR/raptor (Cell Signaling Technology, CS-48648), RICTOR (Cell Signaling Technology, CS-2140), p-AKT (Cell Signaling Technology, CS-4058), p-RPS6KB/p70S6K (Cell Signaling Technology, CS-9206), RPS6KB/p70S6K (Cell Signaling Technology, CS9202), p-MTOR (Cell Signaling Technology, CS-2971), p-EIF4EBP1 (Cell Signaling Technology, CS-9456), EIF4EBP1 (Cell Signaling Technology, CS-9452), MGMT (Cell Signaling Technology, CS-2739S), CTSD/cathepsin D (Cell Signaling Technology, CS-2284), ATG3 (Cell Signaling Technology, CS-3415), ATG5 (Cell Signaling Technology, CS-12994), TP53 (Cell Signaling Technology, CS-9282), cleaved CASP7/caspase 7 (Cell Signaling Technology, CS-9491), TUBA1B/α-Tubulin (Cell Signaling Technology, CS-2125), LMNB1/Lamin B1 (Cell Signaling Technology, CS-13435), ATP6V1A (Abcam, ab -199,326), ATP6V1B2 (Abcam, ab -73,404), MTOR (Abcam, ab-2732), and CTSB/cathepsin B (Abcam, ab58802), TFEB (ThermoFisher Scientific, PAS-34360; 1:100 for IP, 1:200 for IF, 1:1000 for WB), TSC2 (Proteintech, 24601–1-AP), TSC1 (Proteintech, 20988–1-AP), ATP6V1D (Proteintech, 14920– 1-AP), ATP6V1G1 (Proteintech, 16143–1-AP), ATP6V1H (Proteintech, 26683–1-AP), ATP6V1C1 (Proteintech, 16054– 1-AP), AKT (GeneTex, GTX-121937), ATG9A (GeneTex, EPR-5973), CCND1/cyclin D1 (Santa Cruz Biotechnology, SC-753), CCND2/cyclin D2 (Santa Cruz Biotechnology, SC754), CCNDE1/cyclin E1 (Santa Cruz Biotechnology, SC377100), ACTB/actin (Santa Cruz Biotechnology, SC-8432), CTSB/capthepsin D (Santa Cruz Biotechnology, sc -377,124).

Techniques: Expressing, Western Blot